In June 2025, Fractyl presented preclinical data at the American Diabetes Association’s 85th Scientific Sessions that showed ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Texas Attorney General Ken Paxton on Thursday announced a lawsuit alleging that Eli Lilly (NYSE:LLY) bribed his state's medical providers in a bid to persuade them to prescribe the company’s weight ...

Discover Veru Inc.'s Q3 2025 earnings insights, including Phase III enobosarm trial updates, FDA feedback, and nondilutive funding plans for ...

Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

As lawyers who represent whistleblowers under the False Claims Act, we expect a new era of fraud cases tied to GLP-1 drugs, ...

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

Weight loss drugs are big news, and Viking has one in development in both injectable and oral form. Investors are eagerly ...